DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

New Practice Standards Related to Smoking Marijuana for Medical Use
July 26, 2021

For information regarding new rules and forms related to smoking marijuana as an appropriate route of administration, please click here. Continue reading


New Legislation Impacting Your Profession
June 29, 2021

Click here to view a full list of bill summaries from the 2021 Florida Legislative Session that may impact your profession. Continue reading




Supporting Documents

Medical Degree Verification
NICA FORM
Postgraduate Training Verification
License Verification

Supporting Documents - Visiting Physician

NICA FORM